Medicines in China's National Health Insurance System
1st Edition
Published on 22. November 2022
Book
Hardback
64 pages
978-1-032-35111-7 (ISBN)
Description
This book presents the findings of systematic research into the healthcare medicine management policies of China. In-depth comprehensive research has been carried out, targeting multiple issues of particular importance in healthcare medicine management, such as the purchasing, pricing, payment, usage, and the function of commercial healthcare insurance in medical payment. The book goes on to put forward policy advice regarding the aforementioned issues.
More details
Series
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
Professional and scholarly
General
Illustrations
85 s/w Abbildungen, 85 s/w Photographien bzw. Rasterbilder, 39 s/w Tabellen
39 Tables, black and white; 85 Halftones, black and white; 85 Illustrations, black and white
Dimensions
Height: 240 mm
Width: 161 mm
Thickness: 31 mm
Weight
898 gr
ISBN-13
978-1-032-35111-7 (9781032351117)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
China Development Research Foundation
Medicines in China's National Health Insurance System
Book
05/2024
1st Edition
Routledge
€65.00
Shipment within 10-20 days
China Development Research Foundation
Medicines in China's National Health Insurance System
E-Book
11/2022
1st Edition
Routledge
€55.49
Available for download
China Development Research Foundation
Medicines in China's National Health Insurance System
E-Book
11/2022
1st Edition
Routledge
€55.49
Available for download
Person
China Development Research Foundation (CDRF) is a public foundation initiated and led by the Development Research Center of the State Council (DRC) on November 27, 1997. Its mission is to advance good governance and public policy to promote economic development and social progress. Financial support for the Foundation is provided by donations from Chinese and international patrons. Funding is used to support policy research, publications, leadership training, development forums, and academic exchanges, as well as rewarding individuals who make great contribution in policy consulting or related areas of academic research and funding other social philanthropic activities that fit with the goal of the foundation.
Content
1. Research on dynamic mechanisms for adjusting the national list of reimbursable drugs 2. Research on drug procurement mechanisms 3. Research on drug pricing mechanisms 4. Research on drug payment and usage 5. Research on the role of commercial health insurance in reimbursing drug costs 6. Research on drug pricing mechanisms in other countries